The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Autoantibodies to a 140‐kd polypeptide, CADM‐140, in Japanese patients with clinically amyopathic dermatomyositis
Abstract
Objective: To identify novel autoantibodies specific for dermatomyositis (DM), especially those specific for clinically amyopathic DM (C‐ADM). Methods: Autoantibodies were analyzed by immunoprecipitation in 298 serum samples from patients with various connective tissue diseases (CTDs) or idiopathic pulmonary fibrosis (IPF). Antigen specificity of the sera was further examined by immunoblotting and indirect immunofluorescence (IF). The disease specificity and clinical features associated with the antibody of interest were determined. Results: Eight sera recognized a polypeptide of ∼140 kd (CADM‐140 autoantigen) by immunoprecipitation and immunoblotting. Immunoreactivity was detected in the cytoplasm, and indirect IF revealed a granular or reticular pattern. Anti–CADM‐140 antibodies were detected in 8 of 42 patients with DM, but not in patients with other CTDs or IPF. Interestingly, all 8 patients with anti–CADM‐140 antibodies had C‐ADM. Among 42 patients with DM, those with anti–CADM‐140 autoantibodies had significantly more rapidly progressive interstitial lung disease (ILD) when compared with patients without anti–CADM‐140 autoantibodies (50% versus 6%; P = 0.008). Conclusion: These results indicate that the presence of anti–CADM‐140 autoantibodies may be a novel marker for C‐ADM. Further attention should be directed to the detection of rapidly progressive ILD in those patients with anti–CADM‐140 autoantibodies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Towbin, H., Staehelin, T., & Gordon, J. (1979) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.76.9.4350 · Cited by 53,385
Sontheimer, R. D. (2002) · Journal of the American Academy of Dermatology · doi:10.1067/mjd.2002.120621 · Cited by 486
Hirakata, M., Suwa, A., Nagai, S., Kron, M. A., Trieu, E. P., Mimori, T., Akizuki, M., & Targoff, I. N. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.4.2315 · Cited by 187
Self-citation
Cited by
Immune Signaling by RIG-I-like Receptors
Loo, Y.-M., & Gale, M. (2011) · Immunity · doi:10.1016/j.immuni.2011.05.003 · Cited by 1,875
“Subjects that exhibit an accumulation of autoantibodies to MDA5 are often associated with a higher frequency of rapidly progressive interstitial lung disease (Sato et al., 2005; Gono et al., 2010; Nakashima et al., 2010).”
BackgroundMyositis‐specific autoantibodies: an important tool to support diagnosis of myositis
Betteridge, Z., & McHugh, N. (2016) · Journal of Internal Medicine · doi:10.1111/joim.12451 · Cited by 1,056
Idiopathic inflammatory myopathies
Lundberg, I. E., Fujimoto, M., Vencovsky, J., Aggarwal, R., Holmqvist, M., Christopher-Stine, L., Mammen, A. L., & Miller, F. W. (2021) · Nature Reviews Disease Primers · doi:10.1038/s41572-021-00321-x · Cited by 703
Sato, S., Hoshino, K., Satoh, T., Fujita, T., Kawakami, Y., Fujita, T., & Kuwana, M. (2009) · Arthritis & Rheumatism · doi:10.1002/art.24621 · Cited by 604
Self-citationFiorentino, D., Chung, L., Zwerner, J., Rosen, A., & Casciola-Rosen, L. (2011) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2010.09.016 · Cited by 554
Satoh, M., Tanaka, S., Ceribelli, A., Calise, S. J., & Chan, E. K. L. (2017) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-015-8510-y · Cited by 420
McHugh, N. J., & Tansley, S. L. (2018) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2018.56 · Cited by 390
Gono, T., Sato, S., Kawaguchi, Y., Kuwana, M., Hanaoka, M., Katsumata, Y., Takagi, K., Baba, S., Okamoto, Y., Ota, Y., et al. (2012) · Rheumatology · doi:10.1093/rheumatology/kes102 · Cited by 339
Self-citationNakashima, R., Imura, Y., Kobayashi, S., Yukawa, N., Yoshifuji, H., Nojima, T., Kawabata, D., Ohmura, K., Usui, T., Fujii, T., et al. (2010) · Rheumatology · doi:10.1093/rheumatology/kep375 · Cited by 334
Self-citationHamaguchi, Y., Kuwana, M., Hoshino, K., Hasegawa, M., Kaji, K., Matsushita, T., Komura, K., Nakamura, M., Kodera, M., Suga, N., et al. (2011) · Archives of Dermatology · doi:10.1001/archdermatol.2011.52 · Cited by 333
Self-citationManagement of interstitial lung disease associated with connective tissue disease
Mathai, S. C., & Danoff, S. K. (2016) · BMJ · doi:10.1136/bmj.h6819 · Cited by 328
Current Classification and Management of Inflammatory Myopathies
Schmidt, J. (2018) · Journal of Neuromuscular Diseases · doi:10.3233/jnd-180308 · Cited by 324
Gono, T., Kawaguchi, Y., Satoh, T., Kuwana, M., Katsumata, Y., Takagi, K., Masuda, I., Tochimoto, A., Baba, S., Okamoto, Y., et al. (2010) · Rheumatology · doi:10.1093/rheumatology/keq149 · Cited by 319
Self-citationHall, J. C., Casciola‐Rosen, L., Samedy, L., Werner, J., Owoyemi, K., Danoff, S. K., & Christopher‐Stine, L. (2013) · Arthritis Care & Research · doi:10.1002/acr.21992 · Cited by 307
Fujimoto, M., Hamaguchi, Y., Kaji, K., Matsushita, T., Ichimura, Y., Kodera, M., Ishiguro, N., Ueda‐Hayakawa, I., Asano, Y., Ogawa, F., et al. (2012) · Arthritis & Rheumatism · doi:10.1002/art.33403 · Cited by 301
Aggarwal, R., Cassidy, E., Fertig, N., Koontz, D. C., Lucas, M., Ascherman, D. P., & Oddis, C. V. (2014) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2012-201800 · Cited by 301
Self-citationChen, Z., Cao, M., Plana, M. N., Liang, J., Cai, H., Kuwana, M., & Sun, L. (2013) · Arthritis Care & Research · doi:10.1002/acr.21985 · Cited by 288
Self-citationLega, J.-C., Fabien, N., Reynaud, Q., Durieu, I., Durupt, S., Dutertre, M., Cordier, J.-F., & Cottin, V. (2014) · Autoimmunity Reviews · doi:10.1016/j.autrev.2014.03.004 · Cited by 286
Moghadam‐Kia, S., Oddis, C. V., Sato, S., Kuwana, M., & Aggarwal, R. (2016) · Arthritis Care & Research · doi:10.1002/acr.22728 · Cited by 277
Self-citationDermatomyositis With Anti-MDA5 Antibodies: Bioclinical Features, Pathogenesis and Emerging Therapies
Nombel, A., Fabien, N., & Coutant, F. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.773352 · Cited by 262
Anti-MDA5 and anti-TIF1-γ antibodies have clinical significance for patients with dermatomyositis
Hoshino, K., Muro, Y., Sugiura, K., Tomita, Y., Nakashima, R., & Mimori, T. (2010) · Rheumatology · doi:10.1093/rheumatology/keq153 · Cited by 260
Self-citationKishaba, T., McGill, R., Nei, Y., Ibuki, S., Momose, M., Nishiyama, K., Nagano, H., & Yamashiro, S. (2018) · The Journal of Medical Investigation · doi:10.2152/jmi.65.251 · Cited by 24
Metadata
- Authors
- Sato, S., Hirakata, M., Kuwana, M., Suwa, A., Inada, S., Mimori, T., Nishikawa, T., Oddis, C. V., & Ikeda, Y.
- Venue
- Arthritis & Rheumatism
- Publisher
- Wiley
- Published
- 2005-05
- Volume
- 52
- Issue
- 5
- Pages
- 1571-1576
- ISSN
- 0004-3591 (ISSN-L)
- 1529-0131
- OpenAlex
- W2003549180
- Cited by
- 747
- References
- 3
- FWCI
- 5.89
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.